Evidence map›Paper›PMID 36984825›Full record

ArticleMetabolites2023

Aline Rigon Zimmer, Bianca Franco Leonardi, Eduardo Rigon Zimmer, Alexandre Pastoris Muller, Grace Gosmann, Luis Valmor Cruz Portela

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Metabolites, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Aline Rigon ZimmerPharmaceutical Sciences Graduate Program (PPGCF), Faculty of Pharmacy, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre 90610-000, RS, Brazil.ORCID 0000-0002-8309-7068
Bianca Franco LeonardiPharmaceutical Sciences Graduate Program (PPGCF), Faculty of Pharmacy, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre 90610-000, RS, Brazil.
Eduardo Rigon ZimmerGraduate Program in Biological Sciences: Pharmacology and Therapeutics (PPGFT), Department of Pharmacology, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre 90035-003, RS, Brazil.
Alexandre Pastoris MullerDepartment of Biochemistry, Federal University of Santa Catarina (UFSC), Florianópolis 88037-000, SC, Brazil.
Grace GosmannPharmaceutical Sciences Graduate Program (PPGCF), Faculty of Pharmacy, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre 90610-000, RS, Brazil.ORCID 0000-0001-6823-8312
Luis Valmor Cruz PortelaGraduate Program in Biological Science: Biochemistry (PPGBioq), Department of Biochemistry, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre 90035-003, RS, Brazil.
Universidade Federal do Rio Grande do Sul · BRUniversidade Federal de Santa Catarina · BR

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior 0186/2022
6 · The paper itself

Abstract

Metabolic syndrome is a serious health condition reaching epidemic proportions worldwide and is closely linked to an increased risk of cardiovascular problems. The lack of appropriate treatment paves the way for developing new therapeutic agents as a high priority in the current research. In this study, we evaluated the protective effects of

Indexed as

Capsicum baccatumcardiovascular riskdyslipidemiahyperglycemiametabolic syndrome

Identifiers

PMID36984825
PMCPMC10052057
OpenAlexW4323317961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.